14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CLOX vs CLOA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Eldridge AAA CLO ETF (CLOX) is the stronger overall head-to-head candidate over BlackRock ETF Trust II iShares AAA CLO Active ETF (CLOA) in the Tradestie Institutional Equity Comparison Engine, winning 1–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CLOX carries a Unified Composite Score of 67.7/100 (BUY) at $25.57 (N/M Forward P/E, N/A operating margin), whereas CLOA carries 59.0/100 (HOLD) at $51.90 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLOX vs CLOA. Trailing 12-month operating profitability (CLOX N/A vs CLOA N/A) and valuation multiples (CLOX N/M vs CLOA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CLOX vs CLOA Key Questions & Quantitative Answers
As of Nov 16, 2026, Eldridge AAA CLO ETF (CLOX) is the stronger overall head-to-head candidate over BlackRock ETF Trust II iShares AAA CLO Active ETF (CLOA) in the Tradestie Institutional Equity Comparison Engine, winning 1–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CLOX carries a Unified Composite Score of 67.7/100 (BUY) at $25.57 (N/M Forward P/E, N/A operating margin), whereas CLOA carries 59.0/100 (HOLD) at $51.90 (N/M Forward P/E, N/A operating margin). Technically, CLOX sits in a Neutral phase (RSI 52.9, UNCLASSIFIED options structure) and CLOA sits in a Neutral phase (RSI 55.7, UNCLASSIFIED options structure).
CLOX and CLOA split Growth & Scale metrics: CLOX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CLOA at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CLOX generates N/A in USD-normalized revenue versus N/A for CLOA. In operating R&D and SG&A reinvestment, CLOX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CLOA.
CLOX and CLOA trade at balanced relative valuation multiples. CLOX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CLOA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLOX (N/A ROE) versus CLOA (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, CLOX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.00β · 1% Vol realized risk). By comparison, CLOA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.01β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.